Timpanogos Regional Medical Center
Welcome,         Profile    Billing    Logout  
 3 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cummings, James F
NCT05067933: A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine

Completed
2
66
US
VXA-CoV2-1.1-S, Oral Tableted Ad5 COVID-19 Vaccine, Placebo Tablets
Vaxart
COVID-19
05/22
08/23
NCT05626803: A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers

Active, not recruiting
2
135
US
Open label Bivalent GII.4/GI.1 high dose vaccine 2×10 to the power 11 IU/dose, Bivalent GII.4/GI.1 high dose vaccine 2×10 to the power 11 IU/dose, Bivalent GII.4/GI.1 medium dose vaccine 1×10 to the power 11 IU/dose, Placebo
Vaxart
Norovirus Infections
10/23
07/24
NCT06672055: A Study to Evaluate VXA-CoV2-3.1 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection

Recruiting
2
10000
US
VXA-CoV2-3.1, COMIRNATY®, Pfizer-BioNTech mRNA Vaccine
Vaxart
SARS-CoV2, COVID-19
01/26
01/26
G1-1 Challenge, NCT05212168: Norovirus Challenge Study

Completed
1/2
165
US
VXA-G1.1-NN, Placebo Tablets, Norovirus GI.1 Norwalk Virus Inoculum
Vaxart
Norovirus Infections
04/23
10/23
Gerstmann, Dale
No trials found

Download Options